Advances in intelligent systems have opened up new possibilities for the early detection, clinical assessment and personalised treatment of neurodegenerative diseases such as Alzheimer’s and other dementias. The integration of tools based on artificial intelligence (AI), machine learning, smart sensors, multimodal data analysis and interactive digital platforms is revolutionising early diagnosis, therapeutic strategies and continuous monitoring.
This special track aims to bring together researchers, clinicians and technology developers in a multidisciplinary forum to present and analyse innovative approaches that incorporate intelligent technologies into the comprehensive management of the early stages of these diseases.
Topics of interest:
Topics of interest for this special session include (but are not limited to) the following:
- Machine learning and deep learning models for early diagnosis.
- Digital biomarkers and neuroimaging analysis using AI.
- Automated cognitive assessment and intelligent tools.
- Clinical decision support systems.
- AI applications in personalised cognitive interventions.
- Remote monitoring and disease progression prediction.
- Integration of multimodal data (clinical, genomic, behavioural, etc.).
- Ethics and explainability in AI applied to neurodegeneration.
Type of submissions:
- Regular papers: This type of paper is limited to a range of 12-15 pages.
- Short papers: These papers are limited to a range of 6-11 pages.
- Posters papers: This contribution is limited to a total of between 4-6 pages, and it is not possible to extend the length of the document. This type of document will not include an oral presentation during the conference. Authors of this type of document should prepare a real poster to be displayed during the conference. For presentation purposes at the conference, authors should prepare the poster in portrait format. Accepted dimensions are 60 (width) x 80 (length).
- Breakthroughs papers: This modality aims to give visibility to recent research and bring these advances closer to the scientific community, fostering interdisciplinary knowledge and connections between researchers from different areas such as computer science, biology, medicine and bioengineering. Breakthroughs papers may refer to work that has already been published, although the content of the document must be completely original. The contribution is limited to 2-4 pages, and it is not possible to extend the length of the document. The duration of the oral presentation of this type of document will be shorter than the regular one.
Regular and short papers accepted will be included with their own DOI in Lecture Notes in Bioinformatics (LNBI) from Springer. Poster papers accepted will also be published in Lecture Notes in Bioinformatics (LNBI) grouped under the same DOI. In order to encourage more developed contributions, authors are encouraged to expand their papers whenever possible, so that they can be considered as regular papers. The accepted breakthrough papers will be published in the society’s own proceedings which will be available on the official IABiomed website.
More information available at: https://2025.iabiomed.org/
Organizers
- Dr. Rafael Martínez Tomás, Artificial Intelligence Department, Universidad Nacional de Educación a Distancia (UNED), Spain.
- Dr. Mariano Rincón Zamorano, Artificial Intelligence Department, Universidad Nacional de Educación a Distancia (UNED), Spain.
Contact
For further information, please visit the CIABiomed 2025 website at https://2025.iabiomed.org/ or contact the organisers of this special session at rmtomas [at] dia.uned.es.
Call for papers
You can download Call for papers here.
